clinical need News
-
Showcase
Corify Care participated in the CEI Satellite Meeting CinC 2020: Challenges in the Daily Application of ECGI
Last 18th of September, Corify Care CEO and co-founder, Dr. Andreu Climent participated in the CEI Satellite Meeting CinC 2020: ECGI Past, Present, and Future: from Engineering to Clinical Application organised by the Consortium for ECG Imaging. The objective was to discuss engineering hurdles for ECGI being incorporated into clinical practice and are partnering with industry leaders to ...
-
New antibody detection platform offers accelerated multiplex detection of antibodies against pathogens or autoantibodies against biomarkers
VeraPrep Antibody Detection kit, to be introduced at AACC, allows researchers to measure antibodies against any antigen of interest in serum, plasma or saliva. Austin, TX, September 27, 2021 -- Veravas, Inc., an early-stage diagnostics company, has announced the development of its VeraPrep™ Antibody Detection Kit, a new development platform that provides scientists with a ...
-
ELITechGroup Microbiology releases a new rapid test to detect resistance to polymyxins.
Among the most clinically significant multidrug-resistant bacteria are carbapenemase-producing Enterobacteriaceae. Because these bacteria usually remain susceptible to polymyxins, interest in this old class of antibiotics has been recently renewed. However, the increasing use of colistin explains why Enterobacterial strains resistant to colistin are increasingly reported worldwide. Currently ...
By ELITechGroup
-
Reflow Medical Introduces The Spex™LP, The Lowest Profile Shapeable Reinforced Support Catheter
Reflow Medical, Inc., a California-based medical device company, introduces the Reflow™ Spex™ LP (Low Profile) 0.014 and 0.018-inch reinforced support catheters. The new Spex LP is engineered to provide the lowest profile tip for accessing and crossing the tightest and most complex lesions with a supportive system. It also features three radiopaque markers that enhance visibility on ...
-
Acuitas Therapeutics Donates $50,000 to Support Humanitarian Efforts in Ukraine
Acuitas Therapeutics, a Vancouver-based, private biotechnology company that specializes in the development of delivery systems for nucleic acid therapeutics based on lipid nanoparticles, has donated $50,000 to the Canadian Red Cross to support that organization’s humanitarian efforts in Ukraine, President and CEO, Dr. Thomas Madden announced today. Said Dr. Madden: “The unprovoked ...
-
FDA 510(k) Clearance
ENvizion Medical announced that the ENvue™ Electromagnetic Feeding Tube Placement System and ENvizion Feeding Tubes received FDA 510(k) clearance. This new generation of electromagnetic placement technology addresses current technological limitations and meets the growing clinical need for accurate feeding tube placement at bedside. Globally, over 22 million nasal feeding tubes are placed ...
-
Reflow Medical Completes DEEPER LIMUS Clinical Trial Enrollment
Reflow Medical, Inc., a California-based medical device company, has completed enrollment in the DEEPER LIMUS clinical trial (NCT04162418) to evaluate the Temporary Spur Stent System, a patented device designed to treat long, diffuse and severely calcified infrapopliteal disease. The system allows for uniform expansion of the stent to maximize lumen diameter and may reduce acute vessel recoil ...
-
TISSIUM Selected for French Tech 120 Program
TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, announced today it has been named a French Tech 120 company for the 2021 program. French Tech 120 is a growth-stage program by La French Tech, built to provide government-backed support for the 120 fastest growing companies in France. This is the second year in a row that ...
By TISSIUM
-
Abi Coman-Walker Named Chief Operating Officer at Acuitas Therapeutics
Abi Coman-Walker has been promoted to Chief Operating Officer (COO) at Acuitas Therapeutics, Dr. Thomas Madden, Acuitas President & CEO announced recently. Ms. Coman-Walker was the Senior Director of Finance & Operations at the private biotech firm. Prior to joining Acuitas in early 2021, Ms. Coman-Walker worked at HSBC, where she held senior roles in seven countries including: Strategic ...
-
TISSIUM selected for the French Tech 120 Program
TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, announced today it has been nominated in the French Tech 120 of the 2022 program. French Tech 120 is a growth-stage program by La FrenchTech, built to provide government-backed support for the 120 fastest growing companies in France. This is the third year in a row that ...
By TISSIUM
-
Neuros Medical Announces Closing of $20 Million Venture Financing
Neuros Medical, Inc., a neuromodulation company, announced today that it has closed a $20 million Series AA venture capital financing. U.S. Venture Partners led the financing, and was joined by Boston Scientific, Aperture Venture Partners, Osage University Partners, and JumpStart, Inc. Alan Kaganov, Sc.D. and Casey Tansey of U.S. Venture Partners have joined Neuros Medical’s Board of ...
-
Saladax Biomedical, Inc. Acquires Intellectual Property Portfolio for Antipsychotic Drug Tests
Saladax Biomedical, Inc. (Saladax) is pleased to announce that it has acquired a patent portfolio for antipsychotic drug testing from Janssen Pharmaceutica NV. This intellectual property (IP) portfolio includes 17 patent families and has resulted in 33 U.S. patents and 296 patents in ex-U.S. countries. This IP, along with the current Saladax IP, covers the major antipsychotic drugs that are ...
-
AIDOC and IMBIO partner to provide an industry first ai solution to prioritize suspected pulmonary embolism and automatically calculate RV/LV ratio
Aidoc, the leading provider of enterprise AI solutions, and Imbio, a leading provider of medical image analysis for pulmonary and cardiothoracic diseases, announced today a partnership intended to provide the world’s first end-to-end AI solution for pulmonary embolism (PE), with the goal of ultimately improving efficiency and quality of pulmonary embolism detection and treatment. ...
By Aidoc
-
Q’Apel Medical Welcomes Jodie Fam, Vice President and General Manager, International
Q’Apel Medical, Inc., an innovative neurovascular company specializing in developing and commercializing novel access device technology for vascular interventions, is pleased to announce and welcome Jodie Fam as Vice President and General Manager, International. Jodie will be responsible for the leadership and development of International Sales for Q’Apel. Jodie brings more than 20 ...
-
N8 Medical Announces First-in-Human Use of its CeraShield™ Endotracheal Tube
N8 Medical, LLC (N8 Medical) today announced its first-in-human clinical trials of its flagship CeraShield™ endotracheal tube (CeraShield™ ETT) for intensive care unit patients expected to require mechanical ventilation for more than 48 hours. N8 Medical is encouraged by preliminary study data and believes that the CeraShield™ ETT will demonstrate safety and a significant ...
-
Thermo Fisher Scientific Announces Collaborations to Meet Unmet Clinical Needs in Biomarker Discovery and Characterization
Thermo Fisher Scientific, the world leader in serving science, today announced new collaborations of the Thermo Fisher Precision Medicine Science Center (PMSC) with AstraZeneca and the University of Nebraska Medical Center as part of its ongoing development of innovative solutions for unmet needs in clinical biomarker discovery. The new alliances strengthen the PMSC's mission of creating ...
-
Q’Apel Medical Welcomes Thomas Berryman, Chief Financial Officer
Q’Apel Medical, Inc., an innovative neurovascular company specializing in developing and commercializing novel access device technology for vascular interventions, is pleased to announce and welcome Thomas Berryman as Chief Financial Officer. Tom has extensive experience in bringing venture funded medical technology companies from initial startup through product commercialization, revenue ...
-
Microviable announces 1.5 million € investment to advance the company´s microbiota-derived biotherapeutic products.
Microviable Therapeutics SL, a preclinical stage biotechnology company developing orally administered biological drugs based on microbiota-derived products, announced 1.5 million euros seed funding from the private medical group Inmunomet Intolerancia y Disbiosis SL. Microviable will use the seed funding to enhance their therapeutic development platform and advance their pipeline to the clinical ...
-
N8 Medical Announces NHLBI Grant to Develop Antimicrobial Pacemaker Envelope
N8 Medical, LLC (N8 Medical) today announced that the National Heart Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH) indicated its intent to fund N8 Medical’s STTR Phase I grant application for the development of a resorbable envelope to prevent surgical site infections associated with pacemaker implantation surgeries. N8 Medical will be working with researchers ...
-
Michael Artley Named Senior Director, Information Technology at Acuitas Therapeutics
Michael Artley has joined Acuitas Therapeutics as Senior Director of Information Technology (IT), Abi Coman-Walker, Acuitas’ Chief Operating Officer, announced recently. Mr. Artley will lead the company’s commitment in ensuring that information, systems, data and innovation continue to support Acuitas Therapeutics in its global mission of advancing human health. Prior to joining the ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you